Safety of the Use of Radioactive Iodine in Patients With Hyperthyroidism-Reply
- PMID: 31790535
- PMCID: PMC10308509
- DOI: 10.1001/jamainternmed.2019.5123
Safety of the Use of Radioactive Iodine in Patients With Hyperthyroidism-Reply
Comment on
-
Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With Hyperthyroidism.JAMA Intern Med. 2019 Aug 1;179(8):1034-1042. doi: 10.1001/jamainternmed.2019.0981. JAMA Intern Med. 2019. PMID: 31260066 Free PMC article.
-
Safety of the Use of Radioactive Iodine in Patients With Hyperthyroidism.JAMA Intern Med. 2019 Dec 1;179(12):1737-1738. doi: 10.1001/jamainternmed.2019.5117. JAMA Intern Med. 2019. PMID: 31790527 No abstract available.
-
Safety of the Use of Radioactive Iodine in Patients With Hyperthyroidism.JAMA Intern Med. 2019 Dec 1;179(12):1738-1739. doi: 10.1001/jamainternmed.2019.5120. JAMA Intern Med. 2019. PMID: 31790528 No abstract available.
References
-
- Peacock JG, Clemenshaw MN, Banks KP. Don’t feed the fear! Response to Kitahara et al. JAMA Int Med (in press).
-
- Grady EE, Zukotynski K, Greenspan BS. American College of Nuclear Medicine Response to Kitahara, et al. JAMA Int Med (in press).
-
- United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Sources, Effects and Risks of Ionizing Radiation. Annex A: Principles and criteria for ensuring the quality of the Committee’s reviews of epidemiological studies of radiation exposure. Report to the General Assembly, United Nations Scientific Committee on the Effects of Atomic Radiation. New York, NY: UNSCEAR, 2017.
-
- Glinoer D, Cooper DS. The propylthioracil dilemma. Curr Opin Endocrinol Diabetes Obes. 2012;19(5):402–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
